Published 1990 | Version v1
Journal article

6-Substituted tricyclic partial ergoline compounds are selective and potent 5-hydroxytryptamine1A receptor agents

  • 1. Stanford Univ. School of Medicine, CA (USA)

Description

A series of 6 tricyclic partial ergoline derivatives was analyzed using radioligand binding assays. Four agents (LY 178210, LY 254089, LY 197205, and LY 197206) display high affinity for 5-hydroxytryptamine1A (5-HT1A) receptor binding sites labeled by [3H]8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and display ≥ 150 fold selectivity for the 5-HT1A over the 5-HT1D receptor binding site. The most potent agent investigated, LY 178210, is essentially inactive at a total of 12 other neurotransmitter receptor binding sites in the brain. Using a forskolin-stimulated adenylate cyclase assay as a model of 5-HT1A receptor function, LY 178210 was found to display partial agonist activity which was blocked by 10-5 M (-)pindolol. These data indicate that LY 178210 is a potent and selective 5-HT1A receptor partial agonist

Additional details

Publishing Information

Journal Title
Life Sciences
Journal Volume
47
Journal Issue
15
Series
Life Sci.
Journal Page Range
1331-1337
ISSN
0024-3205
CODEN
LIFSA